Accuri C6 Flow Cytometer System

This Article
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, A. D.
Right arrow Articles by Daly, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, A. D.
Right arrow Articles by Daly, J. M.

Journal of Leukocyte Biology, Vol 58, Issue 6 634-642, Copyright © 1995 by Society for Leukocyte Biology


JOURNAL ARTICLE

The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications

AD Hill, HA Naama, SE Calvano and JM Daly
Department of Surgery, New York Hospital/Cornell University Medical Center, New York 10021, USA.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a naturally occurring growth factor produced by several cell types in response to a variety of stimuli. GM-CSF has potent stimulatory effects on the growth and maturation of hematopoietic cells and has profound effects on mature circulating effector cells. Clinical applications of GM-CSF include ameliorating chemotherapy-induced neutropenia and enhancing hematopoietic recovery after bone marrow transplantation. This review evaluates the effect of GM-CSF on myeloid cells and its clinical applications.


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Sebastian, M. Serra, A. Yeramian, N. Serrat, J. Lloberas, and A. Celada
Deacetylase Activity Is Required for STAT5-Dependent GM-CSF Functional Activity in Macrophages and Differentiation to Dendritic Cells
J. Immunol., May 1, 2008; 180(9): 5898 - 5906.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-L. Tso, A. Zisman, A. Pantuck, R. Calilliw, J. M. Hernandez, S. Paik, D. Nguyen, B. Gitlitz, P. I. Shintaku, J. de Kernion, et al.
Induction of G250-targeted and T-Cell-mediated Antitumor Activity against Renal Cell Carcinoma Using a Chimeric Fusion Protein Consisting of G250 and Granulocyte/Monocyte-Colony Stimulating Factor
Cancer Res., November 1, 2001; 61(21): 7925 - 7933.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Shinohara, S. Yano, C. D. Bucana, and I. J. Fidler
Induction of Chemokine Secretion and Enhancement of Contact-Dependent Macrophage Cytotoxicity by Engineered Expression of Granulocyte-Macrophage Colony-Stimulating Factor in Human Colon Cancer Cells
J. Immunol., March 1, 2000; 164(5): 2728 - 2737.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. C.L. Schuh and P. J. Morrissey
Development of a Recombinant Growth Factor and Fusion Protein: Lessons from GM-CSF
Toxicol Pathol, January 1, 1999; 27(1): 72 - 77.
[Abstract] [PDF]


Home page
J. Immunol.Home page
F.-G. Zhu, K. Gomi, and J. S. Marshall
Short-Term and Long-Term Cytokine Release by Mouse Bone Marrow Mast Cells and the Differentiated KU-812 Cell Line Are Inhibited by Brefeldin A
J. Immunol., September 1, 1998; 161(5): 2541 - 2551.
[Abstract] [Full Text] [PDF]